Webinar: Hypofractionation in Proton Therapy
The use of hypofractionated schedules in Proton Therapy is rapidly increasing. Their application has several advantages like the reduction of either overall treatment time or direct and indirect costs, the improvement of the patients’ quality of life, and the increase of the overall system capacity. In the era of “green treatments” and a still limited number of Proton Therapy facilities worldwide, these benefits could translate into more sustainable and fair management of the available resources.
The aim of the present webinar is to highlight radiobiological bases and clinical applications of hypofractionated Proton Therapy in daily clinical practice in order to offer an updated review of the literature as well as results of clinical experiences provided by experts in the field.
Scientific Directors:
Prof. Roberto Orecchia MD
Prof. Barbara A. Jereczek-Fossa MD, Ph.D.
Scientific Coordinator:
Dr. Daniela Alterio MD
Organizational Support: Campus@iba-group.com
Welcome and introduction
Radiobiological basis of hypofractionation in Proton Therapy
Normo vs Hypofractionation: experience from MedAustron Wiener Neustadt, Austria
Hypofractionation of the Central Nervous System tumors
Hypofractionation in Prostate Cancer
Hypofractionated Reirradiation: review of the literature
Discussion and conclusion